{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:02:23Z","timestamp":1768809743087,"version":"3.49.0"},"reference-count":65,"publisher":"Bentham Science Publishers Ltd.","issue":"8","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81660146"],"award-info":[{"award-number":["81660146"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960136"],"award-info":[{"award-number":["81960136"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Department of Science and Technology-Kunming Medical University Joint Special Project on Applied Basic Research","doi-asserted-by":"publisher","award":["202001AY070001-119"],"award-info":[{"award-number":["202001AY070001-119"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Science and Technology Department of Yunnan Province","doi-asserted-by":"publisher","award":["202003AC100014"],"award-info":[{"award-number":["202003AC100014"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Yunnan Provincial Science and Technology Talents and Platform Program","award":["2019 HB050"],"award-info":[{"award-number":["2019 HB050"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CSCR"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Diabetic peripheral neuropathy causes significant pain to patients. Umbilical\ncord mesenchymal stem cells have been shown to be useful in the treatment of diabetes and its complications.\nThe aim of this study was to investigate whether human umbilical cord mesenchymal stem cells\ntreated with interferon-gamma can ameliorate nerve injury associated with diabetes better than human\numbilical cord mesenchymal stem cells without interferon-gamma treatment.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Human umbilical cord mesenchymal stem cells were assessed for adipogenic differentiation,\nosteogenic differentiation, and proliferation ability. Vonfry and a hot disc pain tester were used to evaluate\ntactile sensation and thermal pain sensation in mice. Hematoxylin-eosin and TUNEL staining were\nperformed to visualize sciatic nerve fiber lesions and Schwann cell apoptosis in diabetic mice. Western\nblotting was used to detect expression of the apoptosis-related proteins Bax, B-cell lymphoma-2, and\ncaspase-3 in mouse sciatic nerve fibers and Schwann cells. Real-Time Quantitative PCR was used to detect\nmRNA levels of the C-X-C motif chemokine ligand 1, C-X-C motif chemokine ligand 2, C-X-C motif\nchemokine ligand 9, and C-X-C motif chemokine ligand 10 in mouse sciatic nerve fibers and Schwann\ncells. Enzyme-linked immunosorbent assay was used to detect levels of the inflammatory cytokines, interleukin-\n1\u03b2, interleukin-6, and tumor necrosis factor-\u03b1 in serum and Schwann cells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The adipogenic differentiation capacity, osteogenic differentiation capacity, and proliferation\nability of human umbilical cord mesenchymal stem cells were enhanced after interferon-gamma treatment.\nReal-Time Quantitative PCR revealed that interferon-gamma promoted expression of the adipogenic\nmarkers, PPAR-\u03b3 and CEBP-\u03b1, as well as of the osteogenic markers secreted phosphoprotein 1, bone\ngamma-carboxyglutamate protein, collagen type I alpha1 chain, and Runt-related transcription factor 2.\nThe results of hematoxylin-eosin and TUNEL staining showed that pathological nerve fiber damage and\nSchwann cell apoptosis were reduced after the injection of interferon-gamma-treated human umbilical\ncord mesenchymal stem cells. Expression of the apoptosis-related proteins, caspase-3 and Bax, was significantly\nreduced, while expression of the anti-apoptotic protein B-cell lymphoma-2 was significantly\nincreased. mRNA levels of the cell chemokines, C-X-C motif chemokine ligand 1, C-X-C motif chemokine\nligand 2, C-X-C motif chemokine ligand 9, and C-X-C motif chemokine ligand 10, were significantly\nreduced, and levels of the inflammatory cytokines, interleukin-1\u03b2, interleukin-6, and tumor necrosis\nfactor-\u03b1, were decreased. Tactile and thermal pain sensations were improved in diabetic mice.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Interferon-gamma treatment of umbilical cord mesenchymal stem cells enhanced osteogenic\ndifferentiation, adipogenic differentiation, and proliferative potential. It can enhance the ability of human\numbilical cord mesenchymal stem cells to alleviate damage to diabetic nerve fibers and Schwann cells, in\naddition to improving the neurological function of diabetic mice.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574888x19666230829155046","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T05:23:06Z","timestamp":1693372986000},"page":"1129-1141","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Interferon-gamma Treatment of Human Umbilical Cord Mesenchymal\nStem Cells can Significantly Reduce Damage Associated with Diabetic\nPeripheral Neuropathy in Mice"],"prefix":"10.2174","volume":"19","author":[{"given":"Li-Fen","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, First People's Hospital of Yunnan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Dong","family":"He","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, First People's Hospital of Yunnan Province, China"},{"name":"Medical\nSchool, Kunming University of Science and Technology, Kunming, 650300, Yunnan Province, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Qi","family":"Jiang","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Kunming\nMedical University, Kunming, 650050, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Dan","family":"Wang","sequence":"additional","affiliation":[{"name":"Kunming Yan'an Hospital Kunming, 650051, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Chun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology First People\u2019s Hospital\nof Yunnan Province (The Affiliated Hospital of Kunming University of Science and Technology), Kunming, 650032,\nPeople\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of\nInformation Center, First People's Hospital of Yunnan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Kun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, First People's Hospital of Yunnan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jama.2013.168118","volume":"310","author":"Xu Y.","year":"2013","unstructured":"Xu Y.; Wang L.; He J.; Prevalence and control of diabetes in Chinese adults. JAMA  2013,310(9),948-959","journal-title":"JAMA"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12902-020-0534-5","volume":"20","author":"Shiferaw W.S.","year":"2020","unstructured":"Shiferaw W.S.; Akalu T.Y.; Work Y.; Aynalem Y.A.; Prevalence of diabetic peripheral neuropathy in Africa: A systematic review and meta-analysis. BMC Endocr Disord  2020,20(1),49","journal-title":"BMC Endocr Disord"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"110602","DOI":"10.1016\/j.diabres.2023.110602","volume":"198","author":"Li C.","year":"2023","unstructured":"Li C.; Wang W.; Ji Q.; Prevalence of painful diabetic peripheral neuropathy in type 2 diabetes mellitus and diabetic peripheral neuropathy: A nationwide cross-sectional study in mainland China. Diabetes Res Clin Pract  2023,198,110602","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.pcd.2014.07.006","volume":"9","author":"Li L.","year":"2015","unstructured":"Li L.; Chen J.; Wang J.; Cai D.; Prevalence and risk factors of diabetic peripheral neuropathy in Type 2 diabetes mellitus patients with overweight\/obese in Guangdong province, China. Prim Care Diabetes  2015,9(3),191-195","journal-title":"Prim Care Diabetes"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0025-6196(11)61474-2","volume":"81","author":"Argoff C.E.","year":"2006","unstructured":"Argoff C.E.; Cole B.E.; Fishbain D.A.; Irving G.A.; Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc  2006,81(S4),S3-S11","journal-title":"Mayo Clin Proc"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4093\/dmj.2013.37.2.91","volume":"37","author":"Han J.W.","year":"2013","unstructured":"Han J.W.; Sin M.Y.; Yoon Y.; Cell therapy for diabetic neuropathy using adult stem or progenitor cells. Diabetes Metab J  2013,37(2),91-105","journal-title":"Diabetes Metab J"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrneurol.2011.137","volume":"7","author":"Vincent A.M.","year":"2011","unstructured":"Vincent A.M.; Callaghan B.C.; Smith A.L.; Feldman E.L.; Diabetic neuropathy: Cellular mechanisms as therapeutic targets. Nat Rev Neurol  2011,7(10),573-583","journal-title":"Nat Rev Neurol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1515\/CCLM.2003.194","volume":"41","author":"Dominiczak M.H.","year":"2003","unstructured":"Dominiczak M.H.; Obesity, glucose intolerance and diabetes and their links to cardiovascular disease. Implications for laboratory medicine. Clin Chem Lab Med  2003,41(9),1266-1278","journal-title":"Clin Chem Lab Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2174\/157488806778226821","volume":"1","author":"Porada C.","year":"2006","unstructured":"Porada C.; Zanjani E.; Almeida-Porada G.; Adult mesenchymal stem cells: A pluripotent population with multiple applications. Curr Stem Cell Res Ther  2006,1(3),365-369","journal-title":"Curr Stem Cell Res Ther"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/mt.2009.62","volume":"17","author":"Prockop D.J.","year":"2009","unstructured":"Prockop D.J.; Repair of tissues by adult stem\/progenitor cells (MSCs): Controversies, myths, and changing paradigms. Mol Ther  2009,17(6),939-946","journal-title":"Mol Ther"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/scrt34","volume":"1","author":"Bunnell B.A.","year":"2010","unstructured":"Bunnell B.A.; Betancourt A.M.; Sullivan D.E.; New concepts on the immune modulation mediated by mesenchymal stem cells. Stem Cell Res Ther  2010,1(5),34","journal-title":"Stem Cell Res Ther"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/stem.269","volume":"28","author":"Salem H.K.","year":"2010","unstructured":"Salem H.K.; Thiemermann C.; Mesenchymal stromal cells: Current understanding and clinical status. Stem Cells  2010,28(3),585-596","journal-title":"Stem Cells"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-pathol-011110-130230","volume":"6","author":"Singer N.G.","year":"2011","unstructured":"Singer N.G.; Caplan A.I.; Mesenchymal stem cells: Mechanisms of inflammation. Annu Rev Pathol  2011,6(1),457-478","journal-title":"Annu Rev Pathol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.molimm.2008.12.023","volume":"47","author":"Zdravkovic N.","year":"2009","unstructured":"Zdravkovic N.; Shahin A.; Arsenijevic N.; Lukic M.L.; Mensah-Brown E.P.K.; Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin. Mol Immunol  2009,47(1),28-36","journal-title":"Mol Immunol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/08916930903305641","volume":"43","author":"Volarevic V.","year":"2010","unstructured":"Volarevic V.; Al-Qahtani A.; Arsenijevic N.; Pajovic S.; Lukic M.L.; Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis. Autoimmunity  2010,43(4),255-263","journal-title":"Autoimmunity"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/jdi.12452","volume":"7","author":"Omi M.","year":"2016","unstructured":"Omi M.; Hata M.; Nakamura N.; Transplantation of dental pulp stem cells suppressed inflammation in sciatic nerves by promoting macrophage polarization towards anti\u2010inflammation phenotypes and ameliorated diabetic polyneuropathy. J Diabetes Investig  2016,7(4),485-496","journal-title":"J Diabetes Investig"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e10088","DOI":"10.1371\/journal.pone.0010088","volume":"5","author":"Waterman R.S.","year":"2010","unstructured":"Waterman R.S.; Tomchuck S.L.; Henkle S.L.; Betancourt A.M.; A new mesenchymal stem cell (MSC) paradigm: Polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One  2010,5(4),e10088","journal-title":"PLoS One"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","volume":"8","author":"Jorgovanovic D.","year":"2020","unstructured":"Jorgovanovic D.; Song M.; Wang L.; Zhang Y.; Roles of IFN-\u03b3 in tumor progression and regression: A review. Biomark Res  2020,8(1),49","journal-title":"Biomark Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"e0128647","DOI":"10.1371\/journal.pone.0128647","volume":"10","author":"Li X.","year":"2015","unstructured":"Li X.; Du W.; Ma F.X.; Feng X.; Bayard F.; Han Z.C.; High concentrations of TNF-\u03b1 induce cell death during interactions between human umbilical cord mesenchymal stem cells and peripheral blood mononuclear cells. PLoS One  2015,10(5),e0128647","journal-title":"PLoS One"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/stem.1986","volume":"33","author":"Mounayar M.","year":"2015","unstructured":"Mounayar M.; Kefaloyianni E.; Smith B.; PI3k\u03b1 and STAT1 interplay regulates human mesenchymal stem cell immune polarization. Stem Cells  2015,33(6),1892-1901","journal-title":"Stem Cells"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1242\/jcs.02932","volume":"119","author":"Meirelles L.S.","year":"2006","unstructured":"Meirelles L.S.; Chagastelles P.C.; Nardi N.B.; Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci  2006,119(11),2204-2213","journal-title":"J Cell Sci"},{"key":"ref=22","first-page":"1017","volume":"91","author":"Lu L.L.","year":"2006","unstructured":"Lu L.L.; Liu Y.J.; Yang S.G.; Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica  2006,91(8),1017-1026","journal-title":"Haematologica"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1089\/scd.2013.0537","volume":"23","author":"Carrade Holt D.D.","year":"2014","unstructured":"Carrade Holt D.D.; Wood J.A.; Granick J.L.; Walker N.J.; Clark K.C.; Borjesson D.L.; Equine mesenchymal stem cells inhibit T cell proliferation through different mechanisms depending on tissue source. Stem Cells Dev  2014,23(11),1258-1265","journal-title":"Stem Cells Dev"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.3390\/cells9091948","volume":"9","author":"Cheng Y.C.","year":"2020","unstructured":"Cheng Y.C.; Chu L.W.; Chen J.Y.; Loganin attenuates high glucose-induced schwann cells pyroptosis by inhibiting ROS generation and NLRP3 inflammasome activation. Cells  2020,9(9),1948","journal-title":"Cells"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s13287-022-03143-0","volume":"13","author":"Zhang C.","year":"2022","unstructured":"Zhang C.; Huang L.; Wang X.; Topical and intravenous administration of human umbilical cord mesenchymal stem cells in patients with diabetic foot ulcer and peripheral arterial disease: A phase I pilot study with a 3-year follow-up. Stem Cell Res Ther  2022,13(1),451","journal-title":"Stem Cell Res Ther"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.2147\/IJN.S363777","volume":"17","author":"Xue J.","year":"2022","unstructured":"Xue J.; Sun N.; Liu Y.; Self-assembled nano-peptide hydrogels with human umbilical cord mesenchymal stem cell spheroids accelerate diabetic skin wound healing by inhibiting inflammation and promoting angiogenesis. Int J Nanomedicine  2022,17,2459-2474","journal-title":"Int J Nanomedicine"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/abbs\/gmaa039","volume":"52","author":"Shi R.","year":"2020","unstructured":"Shi R.; Lian W.; Jin Y.; Role and effect of vein-transplanted human umbilical cord mesenchymal stem cells in the repair of diabetic foot ulcers in rats. Acta Biochim Biophys Sin  2020,52(6),620-630","journal-title":"Acta Biochim Biophys Sin"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3132\/dvdr.2007.002","volume":"4","author":"Bailey C.J.","year":"2007","unstructured":"Bailey C.J.; Treating insulin resistance: Future prospects. Diab Vasc Dis Res  2007,4(1),20-31","journal-title":"Diab Vasc Dis Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.2174\/138161211798764825","volume":"17","author":"Kampoli A.M.","year":"2011","unstructured":"Kampoli A.M.; Tousoulis D.; Briasoulis A.; Latsios G.; Papageorgiou N.; Stefanadis C.; Potential pathogenic inflammatory mechanisms of endothelial dysfunction induced by type 2 diabetes mellitus. Curr Pharm Des  2011,17(37),4147-4158","journal-title":"Curr Pharm Des"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S0140-6736(05)70804-7","volume":"365","author":"Sj\u00f6holm A.","year":"2005","unstructured":"Sj\u00f6holm A.; Nystr\u00f6m T.; Endothelial inflammation in insulin resistance. Lancet  2005,365(9459),610-612","journal-title":"Lancet"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2147\/JPR.S21751","volume":"4","author":"Purwata T.","year":"2011","unstructured":"Purwata T.; High TNF-alpha plasma levels and macrophages iNOS and TNF-alpha expression as risk factors for painful diabetic neuropathy. J Pain Res  2011,4,169-175","journal-title":"J Pain Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1212\/01.wnl.0000265062.92340.a5","volume":"69","author":"U\u00e7eyler N.","year":"2007","unstructured":"U\u00e7eyler N.; Rogausch J.P.; Toyka K.V.; Sommer C.; Differential expression of cytokines in painful and painless neuropathies. Neurology  2007,69(1),42-49","journal-title":"Neurology"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1210\/jc.2008-2385","volume":"94","author":"Doupis J.","year":"2009","unstructured":"Doupis J.; Lyons T.E.; Wu S.; Gnardellis C.; Dinh T.; Veves A.; Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab  2009,94(6),2157-2163","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00441-017-2699-4","volume":"372","author":"Bharti D.","year":"2018","unstructured":"Bharti D.; Shivakumar S.B.; Park J.K.; Comparative analysis of human Wharton\u2019s jelly mesenchymal stem cells derived from different parts of the same umbilical cord. Cell Tissue Res  2018,372(1),51-65","journal-title":"Cell Tissue Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/jog.13432","volume":"43","author":"Dabrowski F.A.","year":"2017","unstructured":"Dabrowski F.A.; Burdzinska A.; Kulesza A.; Comparison of the paracrine activity of mesenchymal stem cells derived from human umbilical cord, amniotic membrane and adipose tissue. J Obstet Gynaecol Res  2017,43(11),1758-1768","journal-title":"J Obstet Gynaecol Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41419-021-03524-y","volume":"12","author":"Liu Q.","year":"2021","unstructured":"Liu Q.; Chen X.; Liu C.; Mesenchymal stem cells alleviate experimental immune-mediated liver injury via chitinase 3-like protein 1-mediated T cell suppression. Cell Death Dis  2021,12(3),240","journal-title":"Cell Death Dis"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41419-018-0801-9","volume":"9","author":"Yin Y.","year":"2018","unstructured":"Yin Y.; Hao H.; Cheng Y.; Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice. Cell Death Dis  2018,9(7),760","journal-title":"Cell Death Dis"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fimmu.2013.00258","volume":"4","author":"Inoue S.I.","year":"2013","unstructured":"Inoue S.I.; Niikura M.; Mineo S.; Kobayashi F.; Roles of IFN-\u03b3 and \u03b3\u03b4 T cells in protective immunity against blood-stage malaria. Front Immunol  2013,4,258","journal-title":"Front Immunol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.neulet.2015.04.038","volume":"597","author":"Xia N.","year":"2015","unstructured":"Xia N.; Xu J.M.; Zhao N.; Zhao Q.S.; Li M.; Cheng Z.F.; Human mesenchymal stem cells improve the neurodegeneration of femoral nerve in a diabetic foot ulceration rats. Neurosci Lett  2015,597,84-89","journal-title":"Neurosci Lett"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1007\/s11064-017-2401-y","volume":"42","author":"WenBo W","year":"2017","unstructured":"WenBo W; Fei Z; YiHeng D; Human umbilical cord mesenchymal stem cells overexpressing nerve growth factor ameliorate diabetic cystopathy in rats. Neurochem Res  2017,42(12),3537-3547","journal-title":"Neurochem Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s13287-020-01865-7","volume":"11","author":"Chen G.","year":"2020","unstructured":"Chen G.; Fan X.; Zheng X.; Jin Y.; Liu Y.; Liu S.; Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance via PTEN-mediated crosstalk between the PI3K\/Akt and Erk\/MAPKs signaling pathways in the skeletal muscles of db\/db mice. Stem Cell Res Ther  2020,11(1),401","journal-title":"Stem Cell Res Ther"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.7754\/Clin.Lab.2014.140305","volume":"60","author":"Kong D","year":"2014","unstructured":"Kong D; Zhuang X; Wang D; Umbilical cord mesenchymal stem cell transfusion ameliorated hyperglycemia in patients with type 2 diabetes mellitus. Clin Lab  2014,60(12\/2014),1969-76","journal-title":"Clin Lab"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2337\/dc15-0171","volume":"39","author":"Cai J.","year":"2016","unstructured":"Cai J.; Wu Z.; Xu X.; Umbilical cord mesenchymal stromal cell with autologous bone marrow cell transplantation in established type 1 diabetes: A pilot randomized controlled open-label clinical study to assess safety and impact on insulin secretion. Diabetes Care  2016,39(1),149-157","journal-title":"Diabetes Care"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"557","DOI":"10.5966\/sctm.2012-0025","volume":"1","author":"Waterman R.S.","year":"2012","unstructured":"Waterman R.S.; Morgenweck J.; Nossaman B.D.; Scandurro A.E.; Scandurro S.A.; Betancourt A.M.; Anti-inflammatory mesenchymal stem cells (MSC2) attenuate symptoms of painful diabetic peripheral neuropathy. Stem Cells Transl Med  2012,1(7),557-565","journal-title":"Stem Cells Transl Med"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.stem.2012.05.015","volume":"10","author":"Keating A.","year":"2012","unstructured":"Keating A.; Mesenchymal stromal cells: New directions. Cell Stem Cell  2012,10(6),709-716","journal-title":"Cell Stem Cell"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nri3209","volume":"12","author":"Le Blanc K.","year":"2012","unstructured":"Le Blanc K.; Mougiakakos D.; Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol  2012,12(5),383-396","journal-title":"Nat Rev Immunol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/mt.2011.211","volume":"20","author":"Prockop D.J.","year":"2012","unstructured":"Prockop D.J.; Youn Oh J.; Mesenchymal stem\/stromal cells (MSCs): Role as guardians of inflammation. Mol Ther  2012,20(1),14-20","journal-title":"Mol Ther"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/cdd.2012.26","volume":"19","author":"Li W.","year":"2012","unstructured":"Li W.; Ren G.; Huang Y.; Mesenchymal stem cells: A double-edged sword in regulating immune responses. Cell Death Differ  2012,19(9),1505-1513","journal-title":"Cell Death Differ"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","volume":"2","author":"Ren G.","year":"2008","unstructured":"Ren G.; Zhang L.; Zhao X.; Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell  2008,2(2),141-150","journal-title":"Cell Stem Cell"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"Uccelli A.","year":"2008","unstructured":"Uccelli A.; Moretta L.; Pistoia V.; Mesenchymal stem cells in health and disease. Nat Rev Immunol  2008,8(9),726-736","journal-title":"Nat Rev Immunol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1002\/stem.118","volume":"27","author":"Ren G.","year":"2009","unstructured":"Ren G.; Su J.; Zhang L.; Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells  2009,27(8),1954-1962","journal-title":"Stem Cells"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nri1457","volume":"4","author":"Mellor A.L.","year":"2004","unstructured":"Mellor A.L.; Munn D.H.; Ido expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol  2004,4(10),762-774","journal-title":"Nat Rev Immunol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/eji.200738129","volume":"38","author":"Polchert D.","year":"2008","unstructured":"Polchert D.; Sobinsky J.; Douglas G.W.; IFN-\u03b3 activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol  2008,38(6),1745-1755","journal-title":"Eur J Immunol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"120058","DOI":"10.1016\/j.ijpharm.2020.120058","volume":"592","author":"Li H.","year":"2021","unstructured":"Li H.; Liu Q.; Gao X.; zhang D.; Mao S.; Jia Y.; IFN-\u03b3 gene loaded human umbilical mesenchymal stromal cells targeting therapy for Graft-versus-host disease. Int J Pharm  2021,592,120058","journal-title":"Int J Pharm"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/stem.698","volume":"29","author":"Duijvestein M.","year":"2011","unstructured":"Duijvestein M.; Wildenberg M.E.; Welling M.M.; Pretreatment with interferon-\u03b3 enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis. Stem Cells  2011,29(10),1549-1558","journal-title":"Stem Cells"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"416","DOI":"10.15252\/embr.201439702","volume":"16","author":"Kizil C.","year":"2015","unstructured":"Kizil C.; Kyritsis N.; Brand M.; Effects of inflammation on stem cells: Together they strive? EMBO Rep  2015,16(4),416-426","journal-title":"EMBO Rep"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11010-018-3284-1","volume":"446","author":"Yang C.","year":"2018","unstructured":"Yang C.; Chen Y.; Li F.; The biological changes of umbilical cord mesenchymal stem cells in inflammatory environment induced by different cytokines. Mol Cell Biochem  2018,446(1-2),171-184","journal-title":"Mol Cell Biochem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.cyto.2012.12.007","volume":"61","author":"Ahmed M.","year":"2013","unstructured":"Ahmed M.; Gaffen S.L.; IL-17 inhibits adipogenesis in part via C\/EBP\u03b1, PPAR\u03b3 and Kr\u00fcppel-like factors. Cytokine  2013,61(3),898-905","journal-title":"Cytokine"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10561-012-9354-9","volume":"14","author":"Wei H.","year":"2013","unstructured":"Wei H.; Shen G.; Deng X.; The role of IL-6 in bone marrow (BM)-derived mesenchymal stem cells (MSCs) proliferation and chondrogenesis. Cell Tissue Bank  2013,14(4),699-706","journal-title":"Cell Tissue Bank"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jbiosc.2015.05.017","volume":"121","author":"Li C.","year":"2016","unstructured":"Li C.; Li G.; Liu M.; Zhou T.; Zhou H.; Paracrine effect of inflammatory cytokine-activated bone marrow mesenchymal stem cells and its role in osteoblast function. J Biosci Bioeng  2016,121(2),213-219","journal-title":"J Biosci Bioeng"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","volume":"31","author":"Le Blanc K.","year":"2003","unstructured":"Le Blanc K.; Tammik C.; Rosendahl K.; Zetterberg E.; Ringd\u00e9n O.; HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells. Exp Hematol  2003,31(10),890-896","journal-title":"Exp Hematol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cyto.2016.06.003","volume":"85","author":"Pourgholaminejad A.","year":"2016","unstructured":"Pourgholaminejad A.; Aghdami N.; Baharvand H.; Moazzeni S.M.; The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells. Cytokine  2016,85,51-60","journal-title":"Cytokine"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"e14698","DOI":"10.1371\/journal.pone.0014698","volume":"6","author":"Croitoru-Lamoury J.","year":"2011","unstructured":"Croitoru-Lamoury J.; Lamoury F.M.J.; Caristo M.; Interferon-\u03b3 regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO). PLoS One  2011,6(2),e14698","journal-title":"PLoS One"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.jaci.2016.09.004","volume":"139","author":"Vigo T.","year":"2017","unstructured":"Vigo T.; Procaccini C.; Ferrara G.; IFN-\u03b3 orchestrates mesenchymal stem cell plasticity through the signal transducer and activator of transcription 1 and 3 and mammalian target of rapamycin pathways. J Allergy Clin Immunol  2017,139(5),1667-1676","journal-title":"J Allergy Clin Immunol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13287-017-0550-1","volume":"8","author":"Takeshita K.","year":"2017","unstructured":"Takeshita K.; Motoike S.; Kajiya M.; Xenotransplantation of interferon-gamma-pretreated clumps of a human mesenchymal stem cell\/extracellular matrix complex induces mouse calvarial bone regeneration. Stem Cell Res Ther  2017,8(1),101","journal-title":"Stem Cell Res Ther"}],"container-title":["Current Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574888X19666230829155046","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/220487\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574888X19666230829155046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T10:03:02Z","timestamp":1715940182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/220487\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574888x19666230829155046","relation":{},"ISSN":["1574-888X"],"issn-type":[{"value":"1574-888X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-01-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}